These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 393480)

  • 1. The application of clearance concepts to propranolol disposition in man.
    Wilkinson GR
    Drug Metab Rev; 1979; 10(1):107-23. PubMed ID: 393480
    [No Abstract]   [Full Text] [Related]  

  • 2. The disposition of propranolol. VII. The effects of saturable hepatic tissue uptake on drug clearance by the perfused rat liver.
    Shand DG; Branch RA; Evans GH; Nies AS; Wilkinson GR
    Drug Metab Dispos; 1973; 1(5):679-86. PubMed ID: 4149706
    [No Abstract]   [Full Text] [Related]  

  • 3. The disposition of propranolol. 3. Decreased half-life and volume of distribution as a result of plasma binding in man, monkey, dog and rat.
    Evans GH; Nies AS; Shand DG
    J Pharmacol Exp Ther; 1973 Jul; 186(1):114-22. PubMed ID: 4198771
    [No Abstract]   [Full Text] [Related]  

  • 4. Propranolol disposition in chronic liver disease: a physiological approach.
    Branch RA; Shand DG
    Clin Pharmacokinet; 1976; 1(4):264-79. PubMed ID: 797499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of age and cigarette smoking on propranolol disposition.
    Vestal RE; Wood AJ; Branch RA; Shand DG; Wilkinson GR
    Clin Pharmacol Ther; 1979 Jul; 26(1):8-15. PubMed ID: 445965
    [No Abstract]   [Full Text] [Related]  

  • 6. The disposition of propranolol. 8. General implications of the effects of liver blood flow on elimination from the perfused rat liver.
    Branch RA; Nies AS; Shand DG
    Drug Metab Dispos; 1973; 1(5):687-90. PubMed ID: 4149707
    [No Abstract]   [Full Text] [Related]  

  • 7. The disposition of propranolol. IV. A dominant role for tissue uptake in the dose-dependent extraction of propranolol by the perfused rat liver.
    Evans GH; Wilkinson GR; Shand DG
    J Pharmacol Exp Ther; 1973 Sep; 186(3):447-54. PubMed ID: 4728328
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
    Branch RA; Shand DG; Wilkinson GR; Nies AS
    J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of smoking on the elimination of propranolol hydrochloride.
    Gardner SK; Cady WJ; Ong YS
    Int J Clin Pharmacol Ther Toxicol; 1980 Oct; 18(10):421-4. PubMed ID: 7203717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective induction of propranolol metabolism by smoking: additional effects on renal clearance of metabolites.
    Walle T; Walle UK; Cowart TD; Conradi EC; Gaffney TE
    J Pharmacol Exp Ther; 1987 Jun; 241(3):928-33. PubMed ID: 3598909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis and disposition of low dose oral propranolol.
    MacKichan JJ; Pyszczynski DR; Jusko WJ
    Res Commun Chem Pathol Pharmacol; 1978 Jun; 20(3):531-8. PubMed ID: 674830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug disposition in liver disease.
    Fruncillo RJ
    Am Fam Physician; 1982 Dec; 26(6):167-9. PubMed ID: 7148640
    [No Abstract]   [Full Text] [Related]  

  • 13. Disposition of aminopyrine, antipyrine, diazepam, and indocyanine green in patients with liver disease or on anticonvulsant drug therapy: diazepam breath test and correlations in drug elimination.
    Hepner GW; Vesell ES; Lipton A; Harvey HA; Wilkinson GR; Schenker S
    J Lab Clin Med; 1977 Sep; 90(3):440-56. PubMed ID: 894100
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of age and liver disease on the disposition and elimination of diazepam in adult man.
    Klotz U; Avant GR; Hoyumpa A; Schenker S; Wilkinson GR
    J Clin Invest; 1975 Feb; 55(2):347-59. PubMed ID: 1127104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of propranolol. V. Drug accumulation and steady-state concentrations during chronic oral administration in man.
    Evans GH; Shand DG
    Clin Pharmacol Ther; 1973; 14(4):487-93. PubMed ID: 4723255
    [No Abstract]   [Full Text] [Related]  

  • 16. The disposition of propranolol. II. Hepatic elimination in the rat.
    Shand DG; Rangno RE; Evans GH
    Pharmacology; 1972; 8(4):344-52. PubMed ID: 4657981
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of liver disease and of aging on the disposition and elimination of sedatives.
    Schenker S
    Trans Am Clin Climatol Assoc; 1978; 89():91-9. PubMed ID: 30206
    [No Abstract]   [Full Text] [Related]  

  • 18. Disposition characteristics of coumarin as a function of age in the beagle dog model.
    Ritschel WA; Vachharajani NN
    Arzneimittelforschung; 1993 Sep; 43(9):963-6. PubMed ID: 8240459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of factors influencing drug disposition in chronic liver disease, using the model drug (+)-propranolol.
    Branch RA; James J; Read AE
    Br J Clin Pharmacol; 1976 Apr; 3(2):243-9. PubMed ID: 973958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of pharmacological half-life of propranolol in man].
    Hugues FC; Mougeot G; Munera Y; Julien D; Marche J
    Therapie; 1977; 32(3):321-8. PubMed ID: 929501
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.